精华制药(002349.SZ)发布前三季度业绩，归母净利润1.76亿元，同比增长7.39%

Core Viewpoint - Jinghua Pharmaceutical (002349.SZ) reported a revenue of 1.092 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 4.51% [1] - The net profit attributable to shareholders of the listed company reached 176 million yuan, marking a year-on-year increase of 7.39% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 170 million yuan, showing a year-on-year growth of 9.17% [1] Summary by Category - Revenue Performance - The company achieved a total revenue of 1.092 billion yuan in the first three quarters of 2025, which is a 4.51% increase compared to the same period last year [1] - Net Profit - The net profit attributable to shareholders was reported at 176 million yuan, representing a 7.39% year-on-year growth [1] - The net profit after excluding non-recurring items was 170 million yuan, indicating a 9.17% increase year-on-year [1]